NEW YORK, March 04, 2019 (GLOBE NEWSWIRE) -- Ryah Medtech, Inc. (“RYAH”), a wholly owned subsidiary of PotBotics Inc. (“PotBotics”), proudly announced today that it will be bringing its unique dose-measuring medicinal vaporizer to Oklahoma patients, in partnership with The Peak Dispensary’s statewide network of establishments.

Focused on the global medical cannabis market, RYAH creates smart devices to personalize medication specific to an individual’s needs, and operates an artificial intelligence platform that gathers insightful data on cannabis from seed to consumption.

The Peak Dispensary dedicates itself to providing a premium CBD and Medical Marijuana dispensary experience in Oklahoma. Its goal is to assist patients in finding the cannabis products they need to help supplement or treat their doctor-recommended symptoms. Their products and services operate within Oklahoma law and are focused on helping patients reach their personal height of wellbeing.

This the second US market RYAH will enter, and the first medical-only state to carry RYAH’s state-of-the-art vaporizer.

“We’re extremely pleased to see RYAH entering the Oklahoma market hand in hand with such a prestigious and respected player in the medical cannabis field as The Peak Dispensary, declared Potbotics CEO, David Goldstein. He went on to say: “This exciting partnership will ensure Oklahoma medical patients can access our groundbreaking RYAH vaporizer and enable them to create a controlled medication regimen for themselves”.

For his part, The Peak Dispensary CEO Corbin Wyatt explained that “Peak Dispensary’s partnership with RYAH will put their devices in our 9 establishments throughout the state, contributing to The Peak’s ongoing promise of bringing a no-compromise medical marijuana product offering to Oklahoma patients. Because it enables patients to properly create a cannabis dosing regimen, the RYAH vaporizer clearly contributes to our long-standing goal of ensuring that Oklahoma patients are provided with an unrivaled experience, be it from a product or from a service perspective.”

Noting that “RYAH utilizes disposable medical grade and QR embedded cartridges to ensure consistent and transparent tracking of strains from seed to consumption, Goldstein added that “RYAH will be coming into the market with an array of different cartridges targeted towards the medical and wellness market”.

Oklahoma is the second State where patients can access the RYAH dose-measuring vaporizer: the company is currently finalizing launches in several other States.


By providing users with unprecedented temperature and dose control, the RYAH medicinal vaporizer creates a consistent and replicable vaporizing experience. The state-of-the-art device comes accompanied with a mobile app that puts the patient or medical practitioner in total control and enables them to collect information to track usage and results. The app has already launched in the Apple App Store and Google Play Store. More at WWW.RYAH.COM.

Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to the Company, including: the performance of its device; and RYAH launching in several other States, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: the general business and economic conditions in the regions in which the Company operates; the ability of the Company to execute on key priorities, including the successful completion of acquisitions, business retention, and strategic plans and to attract, develop and retain key executives; difficulty integrating newly acquired businesses; the ability to implement business strategies and pursue business opportunities; disruptions in or attacks (including cyber-attacks) on the Company’s information technology, internet, network access or other voice or data communications systems or services; the evolution of various types of fraud or other criminal behavior to which the Company is exposed; the failure of third parties to comply with their obligations to the Company or its affiliates; the impact of new and changes to, or application of, current laws and regulations; a novel business model; granting of permits and licenses in a highly regulated business; the overall difficult litigation environment, including in the United States; increased competition; changes in foreign currency rates; increased funding costs and market volatility due to market illiquidity and competition for funding; the availability of funds and resources to pursue operations; critical accounting estimates and changes to accounting standards, policies, and methods used by the Company; the occurrence of natural and unnatural catastrophic events and claims resulting from such events; and the risk associated with a business in the cannabis industry. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

For further information, please contact:


Yoray Halevy
Dir. of Business Development
The Peak Dispensary

Corbin Wyatt
Chief Executive Officer

A photo accompanying this announcement is available at